Cullinan Oncology, Inc.

NASDAQ:CGEM

11.6 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -40.56-42.028-37.148-23.803-39.183-32.214-58.141-27.088-24.89174.065-12.892-34.206-18.259-16.4391.419-29.106-11.314-13.875-5.163-4.731-6.583-4.753-4.753
Depreciation & Amortization 0.0760.0770.0760.0770.080.0810.0720.0590.0090.0120.0130.0120.0130.0130.0150.0150.0150.0160.0160.0170.0160.0190.019
Deferred Income Tax 000-6.1310.6071.104019.56800-19.56867.1950.9090.803-1.4890.0870000000
Stock Based Compensation 9.4310.5338.2277.5197.747.927.2597.5135.2718.6086.56512.1454.5574.1653.50814.91000000.0090.009
Change In Working Capital 1.842-1.148-5.9043.31-0.181-4.6481.18-5.011-34.91448.0733.0285.7532.212-4.82-6.6864.4941.3170.9330.107-0.1510.327-0.42-0.42
Accounts Receivables 00000000000000000000000
Change In Inventory 00000000000000000000000
Change In Accounts Payables 0.56-2.1521.2141.542-1.540.461-0.631.145-1.584-3.2073.1371.1450.515-2.371-4.1244.517-0.9761.870.17-0.159000
Other Working Capital 1.2821.004-7.1181.7681.359-5.1090.63-6.156-33.3351.28-0.1094.6081.697-2.449-2.562-0.0232.293-0.937-0.0630.0080.327-0.42-0.42
Other Non Cash Items -4.9279.1143.6670.897-3.204-3.249-1.367-20.0240.171-256.1780.946-66.070.0170.0821.7180.1640.9116.6760.025-0.0040.3730.0650.065
Operating Cash Flow -34.139-36.291-38.247-18.131-34.141-31.006-50.997-24.983-54.353-25.42-21.908-15.171-10.551-16.196-1.515-9.436-9.071-6.25-5.015-4.869-5.867-5.081-5.081
Investing Activities:
Investments In Property Plant And Equipment 00000-0.049-0.159-0.882-0.2510000000.001-0.004-0.004-0.003-0.005-0.004-0.006-0.006
Acquisitions Net 00000-0.012-0.015-5500000.9230-1.4501.4500000
Purchases Of Investments -96.797-324.929-131.369-66.012-136.779-81.453-89.139-160.419-124.127-36.35-57.02-77.262-85.299-213.489-149.763-21.499-16.177-1-31.087-35.38000
Sales Maturities Of Investments 116.675139.817144.325117.48293.82193.612104.482132.661.467.20291.73161.459.70658.89512.03732.93814.2411.5254.20000
Other Investing Activites 0-185.11212.9560.051-0.0430.0120.0155.091527034.711-15.862-25.593-154.594-137.72612.889-1.9371.45-26.887-35.38000
Investing Cash Flow 19.878-185.11212.95651.47-42.95812.1115.184-28.61-57.978300.85234.711-15.862-25.593-154.594-137.72611.44-1.94111.971-26.89-35.385-0.004-0.006-0.006
Financing Activities:
Debt Repayment 0000001.825-2.2000.8000000000000
Common Stock Issued -4.421265.9881.0850.2480.2938.388-0.036-4.3951.4254.4010-267.2680.5790267.268-14.250014.250000
Common Stock Repurchased 0000000000000000000-0.336000
Dividends Paid 00000000000000000000000
Other Financing Activities 1.325262.1961.0850.2480.11238.602-0.036-30.7121.4252.0132.7412.7020.5790.923-2.688124.8971.2060-0.213167.828-0.0420.9220.922
Financing Cash Flow 1.325262.1961.0850.2480.11238.6021.789-32.9121.4252.0133.5412.7020.5790.923264.58124.8971.206014.03783.914-0.0420.9220.922
Other Information:
Effect Of Forex Changes On Cash 000080.191-16.45700000000000000000
Net Change In Cash -12.93640.793-24.20633.587-76.98719.706-34.024-86.505-110.906277.44516.344-28.331-35.565-169.867125.339126.901-9.8065.721-17.86843.66-5.913-4.165-4.165
Cash At End Of Period 102.085115.02174.22898.43464.847141.834122.128156.152242.657353.56376.11859.77488.105123.67293.537168.19841.29751.10345.38263.2519.5925.503-4.165